TLDR Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.
This study explored the role of ferroptosis, a type of cell death associated with oxidative stress, in alopecia areata (AA), a common hair loss condition. By analyzing transcriptome data from AA patients and controls, the researchers identified four ferroptosis-related genes (SLC40A1, LCN2, CREB5, and SLC7A11) as potential biomarkers for AA. They used machine learning techniques, including SVM-RFE and LASSO regression, for feature selection and constructed a nomogram to predict AA with high accuracy (AUC = 0.9052). The expression of these genes was confirmed to be reduced in AA patients through immunofluorescence, with significant differences observed for SLC40A1 and CREB5. These genes were primarily localized to the outer root sheath and near the sebaceous glands. The study's integration of immune cell infiltration analysis and machine learning provides new insights into AA diagnostics and therapeutics, highlighting the connection between AA and ferroptosis.
7 citations
,
August 2023 in “Journal of the American Academy of Dermatology” JAK inhibitors offer new hope for treating severe alopecia areata.
23 citations
,
July 2023 in “Proceedings of the National Academy of Sciences” CD8+ T cells drive alopecia areata, while regulatory T cells are protective.
June 2023 in “Antioxidants” Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.
13 citations
,
September 2022 in “Frontiers in immunology” Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.
7 citations
,
March 2022 in “Journal of the American Academy of Dermatology” Stress can trigger or worsen alopecia areata.
February 2022 in “Journal of Cosmetic Dermatology” Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.
290 citations
,
August 2021 in “Clinical Reviews in Allergy & Immunology” JAK inhibitors show promise for treating alopecia areata, but more research is needed.
42 citations
,
April 2021 in “JCI insight” Blocking JAK3 signaling can reverse hair loss from alopecia areata.
196 citations
,
September 2016 in “JCI insight” Ruxolitinib effectively regrows hair in most patients with severe hair loss.